Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jan 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The CUSTOM-NF-STROKE clinical trial is studying a technique called neurofeedback (NF) to help improve movement recovery in patients who have had a stroke. Neurofeedback involves providing real-time feedback to patients about their brain activity while they perform tasks, which helps them learn to control their brain functions better. This trial is comparing a standard NF method with a personalized NF approach that is tailored to each patient's needs and preferences based on their responses to questionnaires.
To participate in this study, you must be an adult over 18 years old who has experienced a stroke and has difficulty moving one side of your body (known as hemiplegia). You should be between 15 days and 6 months post-stroke and able to sit comfortably for about an hour. If you join the trial, you can expect to engage in NF sessions aimed at helping you improve your motor skills. This research is currently recruiting participants, and it’s important to note that certain conditions, like severe epilepsy or specific neurological issues, may prevent you from being eligible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Man, woman, over 18 years old
- • Motor deficit of the upper limb type of hemiplegia, secondary to a hemorrhagic or ischemic stroke authenticated by brain imaging (MRI or CT)
- • Post-stroke patients in the subacute phase, between 15 days and 6 months after the stroke
- • Correct or corrected vision allowing reading at a distance of 0 to 2m
- • Ability to maintain a seated position for 1 hour
- • Patient affiliated to a social security scheme or beneficiary of such a scheme
- • Informed patient having signed consent
- Exclusion Criteria:
- • Minors (age \< 18 years)
- • Phasic disorder limiting comprehension corresponding to a Boston Diagnostic Aphasia Examination (BDAE) score \< 4
- • Attentional disorder not allowing sufficient attention to be maintained for 1 hour
- • History of known stroke with motor sequelae.
- • Known peripheral neurological pathology affecting the paretic upper limb.
- • Other known central neurological pathology
- • Factors hindering EEG acquisition (scalp pathology, abnormal cervico-cephalic movements, cranial metal implants)
- • Unstabilized epilepsy
- • Refusal to participate in the study
- • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- • Pregnant, parturient, or breastfeeding patient
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Trial Officials
GASQ David, MD
Principal Investigator
University Hospital, Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported